Lowers the risk of cardiovascular mortality. ANDA 76704, held by Mylan. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 76704 (Metoprolol Tartrate), held by Mylan, was first approved by FDA on Jan 16, 2004, with 8 approved supplements and 0 published complete response letters.
Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 16, 2004 | Original application | Approved | None posted |
| Metoprolol Tartrate25MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate50MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate100MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate37.5MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate75MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Jun 3, 2024 | Supplement 45Labeling ยท Standard review | Approved | None posted |
| Jun 3, 2024 | Supplement 41Labeling ยท Standard review | Approved | None posted |
| Mar 18, 2015 | Supplement 21Manufacturing | Approved | None posted |
| Feb 6, 2015 | Supplement 20Labeling ยท Standard review | Approved | None posted |
| Sep 20, 2011 | Supplement 17Labeling | Approved | None posted |
| Mar 12, 2010 | Supplement 14Labeling | Approved | None posted |
| Oct 21, 2008 | Supplement 10Labeling | Approved | None posted |
| May 16, 2008 | Supplement 9Labeling | Approved | None posted |
| Jan 16, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters